Renalytix plc (RNLXY) Insider Trading Disclosures
Renalytix plc (RNLXY) is a publicly traded company on the OTC, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RNLXY
CIK: 1811115
Exchange: OTC
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 06/30
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CohnReznick LLP
Auditor SinceSince 6/30/2024 12:00:00 AM
Lead Engagement PartnerTimothy Garland
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-02-23 | — | SCHEDULE 13D/A Filing | 0001104659-26-018599 | View SEC Doc Filr Page |
| F-6 POS | 2025-12-03 | — | F-6 POS Filing | 0001193805-25-001709 | View SEC Doc Filr Page |
| F-6 POS | 2025-09-04 | — | F-6 POS Filing | 0001193805-25-001256 | View SEC Doc Filr Page |
| EFFECT | 2025-07-30 | — | EFFECT Filing | 9999999995-25-002402 | View SEC Doc Filr Page |
| EFFECT | 2025-07-30 | — | EFFECT Filing | 9999999995-25-002400 | View SEC Doc Filr Page |
| EFFECT | 2025-07-30 | — | EFFECT Filing | 9999999995-25-002399 | View SEC Doc Filr Page |
| EFFECT | 2025-07-30 | — | EFFECT Filing | 9999999995-25-002398 | View SEC Doc Filr Page |
| EFFECT | 2025-07-30 | — | EFFECT Filing | 9999999995-25-002397 | View SEC Doc Filr Page |
| 424B3 | 2025-07-30 | — | 424B3 Filing | 0001193805-25-001128 | View SEC Doc Filr Page |
| 15-12G | 2025-07-30 | — | FORM 15-12G | 0001213900-25-069259 | View SEC Doc Filr Page |
| POS AM | 2025-07-29 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 | 0001213900-25-068777 | View SEC Doc Filr Page |
| POS AM | 2025-07-29 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 | 0001213900-25-068773 | View SEC Doc Filr Page |
| POS AM | 2025-07-29 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 | 0001213900-25-068772 | View SEC Doc Filr Page |
| POS AM | 2025-07-29 | — | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM F-3 ON FORM S-3 | 0001213900-25-068769 | View SEC Doc Filr Page |
| POS AM | 2025-07-29 | — | POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-3 ON FORM S-3 | 0001213900-25-068768 | View SEC Doc Filr Page |
| S-8 POS | 2025-07-25 | — | REGISTRATION STATEMENT | 0001213900-25-067774 | View SEC Doc Filr Page |
| S-8 POS | 2025-07-25 | — | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 | 0001213900-25-067773 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-04-30 | — | SCHEDULE 13G/A Filing | 0001610520-25-000062 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-04-30 | — | SCHEDULE 13G/A Filing | 0001610520-25-000061 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-02-10 | — | SCHEDULE 13G Filing | 0001610520-25-000008 | View SEC Doc Filr Page |
| 8-K | 2025-01-16 | 2025-01-16 | CURRENT REPORT | 0001213900-25-004220 | View SEC Doc Filr Page |
| 8-K | 2024-12-20 | 2024-12-19 | CURRENT REPORT | 0001213900-24-111219 | View SEC Doc Filr Page |
| DEF 14A | 2024-11-25 | 2024-12-19 | PROXY STATEMENT | 0001213900-24-102087 | View SEC Doc Filr Page |
| 8-K/A | 2024-11-19 | 2024-09-26 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-24-100211 | View SEC Doc Filr Page |
| 10-Q | 2024-11-19 | 2024-09-30 | 10-Q | 0000950170-24-128687 | View SEC Doc Filr Page |